Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial
Cole, Peter D, McCarten, Kathleen M, Pei, Qinglin, Spira, Menachem, Metzger, Monika L, Drachtman, Richard A, Horton, Terzah M, Bush, Rizvan, Blaney, Susan M, Weigel, Brenda J, Kelly, Kara MLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30426-1
Date:
August, 2018
File:
PDF, 346 KB
english, 2018